cirrhosis

Treating hepatitis C by blocking a cellular microRNA

2 Comments / Basic virology, Information / By Vincent Racaniello

Miravirsen is a drug that binds to and blocks the function of a cellular microRNA called miR-122 that is required for the replication of hepatitis C virus (HCV). Treatment of chimpanzees chronically infected with HCV with this drug leads to suppression of viral replication. The results of a phase 2b human clinical trial in HCV …

Treating hepatitis C by blocking a cellular microRNA Read More »

New hepatitis C antiviral drugs

14 Comments / Information / By Vincent Racaniello

Nearly 3% of the world’s population – about 175,000,000 individuals – are infected with hepatitis C virus (HCV), and 3-4 million new infections are added each year. A high percentage of these become life long, chronic infections, which may lead to cirrhosis, hepatocellular carcinoma, and death. No vaccine is available, and the only antiviral treatment, …

New hepatitis C antiviral drugs Read More »

cirrhosis

Start typing and press enter to search